Anti-Mouse/Human IL-5 Antibody (TRFK5)

[1]Mathur M, et al. TRFK-5 reverses established airway eosinophilia but not established hyperresponsiveness in a murine model of chronic asthma. Am J Respir Crit Care Med. 1999 Feb;159 (2) :580-7.|[2]Xu JY, et al. Interleukin-5-induced eosinophil population improves cardiac function after myocardial infarction. Cardiovasc Res. 2022 Jul 20;118 (9) :2165-2178.|[3]Garlisi CG, et al. Effects of chronic anti-interleukin-5 monoclonal antibody treatment in a murine model of pulmonary inflammation. Am J Respir Cell Mol Biol. 1999 Feb;20 (2) :248-55.|[4]Shardonofsky FR, et al. Therapeutic efficacy of an anti-IL-5 monoclonal antibody delivered into the respiratory tract in a murine model of asthma. J Allergy Clin Immunol. 1999 Jul;104 (1) :215-21.